These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 15335314)

  • 21. Recent progress in allergen immunotherapy.
    Nouri-Aria KT
    Iran J Immunol; 2008 Mar; 5(1):1-24. PubMed ID: 18319521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvants and vector systems for allergy vaccines.
    Moingeon P; Lombardi V; Saint-Lu N; Tourdot S; Bodo V; Mascarell L
    Immunol Allergy Clin North Am; 2011 May; 31(2):407-19, xii. PubMed ID: 21530828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of Th1/Th2 Bias of STING Agonists Coated on Microneedles for Possible Use in Skin Allergen Immunotherapy.
    Shakya AK; Lee CH; Uddin MJ; Gill HS
    Mol Pharm; 2018 Nov; 15(11):5437-5443. PubMed ID: 30299105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allergen immunotherapy in allergic rhinitis: current use and future trends.
    Klimek L; Pfaar O; Bousquet J; Senti G; Kündig T
    Expert Rev Clin Immunol; 2017 Sep; 13(9):897-906. PubMed ID: 28532268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel mannoside-glycocluster adjuvant: Compared in vitro to CpG ODN and MPL and tested in vivo in mouse asthma model.
    Mäkinen K; Mukherjee C; Leino M; Panchadhayee R; Lehto M; Wolff H; Alenius H; Leino R; Savolainen J
    Allergol Immunopathol (Madr); 2016; 44(1):9-17. PubMed ID: 26395525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sublingual allergen immunotherapy: immunological mechanisms and prospects for refined vaccine preparation.
    O'Hehir RE; Sandrini A; Anderson GP; Rolland JM
    Curr Med Chem; 2007; 14(21):2235-44. PubMed ID: 17896972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allergens and Adjuvants in Allergen Immunotherapy for Immune Activation, Tolerance, and Resilience.
    Jensen-Jarolim E; Roth-Walter F; Jordakieva G; Pali-Schöll I
    J Allergy Clin Immunol Pract; 2021 May; 9(5):1780-1789. PubMed ID: 33753052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of a short course of specific immunotherapy in patients with allergic rhinoconjunctivitis to ragweed pollen.
    Patel P; Holdich T; Fischer von Weikersthal-Drachenberg KJ; Huber B
    J Allergy Clin Immunol; 2014 Jan; 133(1):121-9.e1-2. PubMed ID: 23870670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allergoids for Allergy Treatment.
    Carnes J; Gallego MT; Moya R; Iraola V
    Recent Pat Inflamm Allergy Drug Discov; 2018; 12(2):110-119. PubMed ID: 29473530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Specific immunotherapy using allergens apropos of specific immunotherapy by the sublingual route].
    Sabbah A
    Allerg Immunol (Paris); 1998 Sep; 30(7):221-8. PubMed ID: 9823421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A protective allergy vaccine based on CpG- and protamine-containing PLGA microparticles.
    Martínez Gómez JM; Fischer S; Csaba N; Kündig TM; Merkle HP; Gander B; Johansen P
    Pharm Res; 2007 Oct; 24(10):1927-35. PubMed ID: 17541735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tolerance induction after specific immunotherapy with pollen allergoids adjuvanted by monophosphoryl lipid A in children.
    Rosewich M; Schulze J; Eickmeier O; Telles T; Rose MA; Schubert R; Zielen S
    Clin Exp Immunol; 2010 Jun; 160(3):403-10. PubMed ID: 20345983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety evaluation of a new allergy vaccine containing the adjuvant monophosphoryl lipid A (MPL) for the treatment of grass pollen allergy.
    Baldrick P; Richardson D; Wheeler AW; Woroniecki SR
    J Appl Toxicol; 2004; 24(4):261-8. PubMed ID: 15300713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A preventive immunization approach against insect bite hypersensitivity: Intralymphatic injection with recombinant allergens in Alum or Alum and monophosphoryl lipid A.
    Jonsdottir S; Svansson V; Stefansdottir SB; Schüpbach G; Rhyner C; Marti E; Torsteinsdottir S
    Vet Immunol Immunopathol; 2016 Apr; 172():14-20. PubMed ID: 27032498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intranasal, liposome-adjuvanted cockroach allergy vaccines made of refined major allergen and whole-body extract of Periplaneta americana.
    Meechan P; Tungtrongchitr A; Chaisri U; Maklon K; Indrawattana N; Chaicumpa W; Sookrung N
    Int Arch Allergy Immunol; 2013; 161(4):351-62. PubMed ID: 23689057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New approaches for allergen-specific immunotherapy].
    Cantillo JF; Puerta L
    Biomedica; 2010; 30(3):440-53. PubMed ID: 21713346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvants in Allergen-Specific Immunotherapy: Modulating and Enhancing the Immune Response.
    Zubeldia JM; Ferrer M; Dávila I; Justicia JL
    J Investig Allergol Clin Immunol; 2019; 29(2):103-111. PubMed ID: 30418155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative study of adjuvants for allergen-specific immunotherapy in a murine model.
    de la Torre MV; Baeza ML; Nájera L; Zubeldia JM
    Immunotherapy; 2018 Oct; 10(14):1219-1228. PubMed ID: 30244623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms underlying allergy vaccination with recombinant hypoallergenic allergen derivatives.
    Linhart B; Valenta R
    Vaccine; 2012 Jun; 30(29):4328-35. PubMed ID: 22100888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allergen-related approaches to immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.